News

15/06/2021
Scientists discover a new regulator of antiviral and antitumor immunity
Researchers at SR-Tiget identified a novel mechanism responsible for regulating innate immunity, with important implications in oncology, infectious diseases and for optimizing gene therapy protocols.
MORE
04/06/2021
Muscular Dystrophy: a new possible therapeutic approach
Researchers at San Raffaele succeeded in slowing down skeletal muscle degeneration, in two animal models of muscular dystrophies, by using a protein engineered in laboratory
MORE
22/01/2021
Gene editing: getting closer to clinical application for a rare genetic disease
New study demonstrates that CRIPSR-Cas9 is able to correct the genetic defect underlying hyper IgM syndrome in an animal model of the disease
MORE
21/12/2020
EC approval for Libmeldy
Developed thanks to more than 15 years of research by the San Raffaele Telethon Institute for Gene Therapy in Milan, Libmeldy is the first therapy approved for eligible patients with early-onset MLD
MORE